Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxycycline in Sporadic Creutzfeldt-Jakob Disease
DRKS00000179Phase 2Recruiting
- Sponsor
- Universitätsmedizin Göttingen
- Start
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in sporadic Creutzfeldt-Jakob disease (sCJD) comparing Doxycycline with Placebo (2 arms). Started Aug 2009; status: recruiting.
02
Drugs
doxycycline
03
Conditions
sporadic Creutzfeldt-Jakob disease (sCJD)
Beyond the preview
Go deeper on DRKS00000179.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00000179.